Home  >  Products  >  IAPP (islet amyloid polypeptide) Blocking Peptide (the N terminal of IAPP)(100ug)
IAPP (islet amyloid polypeptide) Blocking Peptide (the N terminal of IAPP)(100ug)

IAPP (islet amyloid polypeptide) Blocking Peptide (the N terminal of IAPP)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IAPP Antibody(ARP41728_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP41728
Size: 100ug
Weight: 4kDa
Gene: 3375
Format: Lyophilized powder
Target: Islet, or insulinoma, amyloid polypeptide is commonly found in pancreatic islets of patients suffering diabetes mellitus type II, or harboring an insulinoma. While the assosciation of amylin with the development of type II diabetes has been known for some time, a direct causative role for amylin has been harder to establish. Studies suggest that amylin, like the related beta-amyloid (Abeta) associated with Alzheimer's disease, can induce apoptotic cell-death in particular cultured cells, an effect that may be relevant to the development of type II diabetes.
Alternative names: AMYLIN; DAP; IAP
See Full Product Listings >